FDA ODAC Meeting 3/31/2009

This meeting was to consider the approval of Avastin for recurrent glioblastomas. The committee voted 10-0 in favor of approval!
I participated in the meeting as a patient advocate. I presented a speech to the committee, accompanied by a slideshow and also presented a CD to the committee which contained letters from our members.


Note: the documents are huge and may take time. You can save them to your hard drive by right clicking the link and select save as!